Is the creation of biotech companies as a logical extension of scientific research work worthwhile? Read under the link below the viewpoints of Jean Stéphenne, former GlaxoSmithKline CEO and Prof. Cédric Blanpain.
“Il nous faut des chercheurs qui puissent écouter”, L’Echo, 10 December 2018. PDF